Patient Counseling in C3GN: From Disease Education to Shared Decision-Making
On the Frontlines of C3GPatient Counseling in C3GN: From Disease Education to Shared Decision-Making
Challenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
On the Frontlines of C3GChallenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
HIF-PHIs for Anemia in CKD: A Novel Treatment Approach
Clinician's RoundtableHIF-PHIs for Anemia in CKD: A Novel Treatment Approach
Patient-Centered Care for Anemia in CKD: Key Considerations for HIF-PHI Therapy
Clinician's RoundtablePatient-Centered Care for Anemia in CKD: Key Considerations for HIF-PHI Therapy
Anemia in CKD: Understanding the KDIGO 2025 Clinical Practice Guideline
Clinician's RoundtableAnemia in CKD: Understanding the KDIGO 2025 Clinical Practice Guideline
Advancing C3G Care with the Approval of a Complement Factor B Inhibitor
On the Frontlines of C3GAdvancing C3G Care with the Approval of a Complement Factor B Inhibitor
Upgrade Your Adult Patients’ IgAN Treatment
Medical Industry FeatureUpgrade Your Adult Patients’ IgAN Treatment
IgAN Insights: The Potential Role of the Complement System in Disease Progression
Medical Industry FeatureIgAN Insights: The Potential Role of the Complement System in Disease Progression
Identifying Patients at High-Risk for IgAN Progression: Key Factors to Know
Medical Industry FeatureIdentifying Patients at High-Risk for IgAN Progression: Key Factors to Know
The Pathogenesis of Complement 3 Glomerulopathy (C3G)
Medical Industry FeatureThe Pathogenesis of Complement 3 Glomerulopathy (C3G)
The Endothelin System and IgAN: Emerging Evidence
Medical Industry FeatureThe Endothelin System and IgAN: Emerging Evidence
IgAN Insights: The Impact of Proteinuria
Medical Industry FeatureIgAN Insights: The Impact of Proteinuria
- 04/23/2025
- 04/22/2025
- 04/17/2025
- 04/10/2025
- 04/10/2025
- 04/08/2025